Ledger.Open graph →
SEC Form D · Amendment · filed September 15, 2015

Pronutria Biosciences, Inc

Offering
—
Sold
$39.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John B. Mendlein · CAMBRIDGE, MADirectorAndrew Smith · Philadelphia, PAExecMarika Tooze · Philadelphia, PAExec · DirectorChristopher R. Manning · NEW YORK, NYDirectorPeter B. Hutt · CAMBRIDGE, MADirectorRobert Connelly · CAMBRIDGE, MAExec · DirectorRichard Fonash · Philadelphia, PAExec · DirectorNoubar Afeyan · CAMBRIDGE, MADirectorStephen Hoge · CAMBRIDGE, MADirectorJeff B. Moore · CAMBRIDGE, MAExecGary B. Pisano · CAMBRIDGE, MADirectorSusan Mullin · Philadelphia, PADirectorJennifer A. Nichols · Philadelphia, PADirectorDavid Berry · CAMBRIDGE, MADirectorCharles Cooney · CAMBRIDGE, MADirectorCharles Ayres · NEW YORK, NYDirectorJeffrey L. Cotton · Philadelphia, PADirectorAlan R. Goodson · Philadelphia, PADirectorEugene D. James · NEW YORK, NYDirectorFrank S. Ioppolo · Lake Mary, FLDirectorChristopher Edwards · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗